Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential

References

• Chang Y, Bluteau D, Debili N, Vainchenker W. From hematopoietic stem cells to platelets. J Thromb Haemost. 2007;5(Suppl 1):318–27.
   PubMed Web of Science ®Google Scholar
• Vitrat N, Cohen-Solal K, Pique C, Le Couedic JP, Norol F, Larsen AK, . Endomitosis of human megakaryocytes are due to abortive mitosis. Blood. 1998;91:3711–23.
   PubMed Web of Science ®Google Scholar
• Mattia G, Vulcano F, Milazzo L, Barca A, Macioce G, Giampaolo A, . Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood. 2002; 99:888–97.
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S. Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents. Sem Hematol. 2009;46:S26–32.
   PubMed Web of Science ®Google Scholar
• Stanworth SJ, Hyde C, Heddle N, Rebulla P, Brunskill S, Murphy MF. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database of Systematic Reviews. 2004:CD004269. Available at: http://mrw.interscience.wiley.com/cochrane/clsysrev/ articles/CD004269/pdf_fs.html. Accessed 4 Sep 2007.
   Google Scholar
• Stroncek DF, Rebulla P. Platelet transfusions. Lancet. 2007; 370:427–38.
   PubMed Web of Science ®Google Scholar
• Vassallo RR, Murphy S. A critical comparison of platelet preparation methods. Curr Opin Hematol. 2006;13:323–30.
   PubMed Web of Science ®Google Scholar
• Pereira A, Sanz C. Effect of extending the platelet storage time on platelet utilization: predictions from a mathematical model of prophylactic platelet support. Transfus Med. 2007;17: 119–27.
   PubMed Web of Science ®Google Scholar
• Dutcher JP. Transfusion supportive care. Wiernik PH. Adult Leukemias. Hamilton: BC Decker; 2001. 307–15.
   Google Scholar
• Mostafa SS, Miller WM, Papoutsakis ET. Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes. Br J Haematol. 2000;111: 879–89.
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Winter JN, Meng Y, Cohen I. Ex vivo expansion of early and late megakaryocyte progenitors. J Hematother Stem Cell Res. 2000;9:913–21.
   PubMedGoogle Scholar
• Case J, Hicks C, Trickett A, Kwan YL, Manoharan A. The expansion of megakaryocyte progenitors from CD34+-enriched mobilized peripheral blood stem cells is inhibited by Flt3-L. J Interferon Cytokine Res. 2006;26:76–82.
   PubMed Web of Science ®Google Scholar
• de Bruyn C, Delforge A, Martiat P, Bron D. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. Stem Cells Dev. 2005; 14:415–24.
   PubMed Web of Science ®Google Scholar
• Balducci E, Azzarello G, Valenti MT, Capuzzo GM, Pappagallo GL, Pilotti I, . The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial. Stem Cells. 2003;21:33–40.
   PubMed Web of Science ®Google Scholar
• Drayer AL, Sibinga CT, Blom NR, de Wolf JT, Vellenga E. The in vitro effects of cytokines on expansion and migration of megakaryocyte progenitors. Br J Haematol. 2000;109: 776–84.
   PubMed Web of Science ®Google Scholar
• Halle P, Rouzier C, Kanold J, Boiret N, Rapatel C, Mareynat G, . Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells. Ann Hematol. 2000;79:13–9.
   PubMed Web of Science ®Google Scholar
• Schipper LF, Brand A, Reniers N, Melief CJ, Willemze R, Fibbe WE. Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol. 2003;31:324–30.
   PubMed Web of Science ®Google Scholar
• van den Oudenrijn S, von dem Borne AE, de Haas M. Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol. 2000;28:1054–61.
   PubMed Web of Science ®Google Scholar
• Cortin V, Garnier A, Pineault N, Lemieux R, Boyer L, Proulx C. Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. Exp Hematol. 2005;33:1182–91.
   PubMed Web of Science ®Google Scholar
• Chow DC, Wenning LA, Miller WM, Papoutsakis ET. Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J. 2001;81:685–96.
   PubMed Web of Science ®Google Scholar
• Taichman RS. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood. 2005;105:2631–9.
   PubMed Web of Science ®Google Scholar
• Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol. 2006;6:93–106.
   PubMed Web of Science ®Google Scholar
• Weiss LP. Functional organization of the hematopoietic tissues. Hoffman R, Benz EJJ, Shattil SJ, Furie B, Cohen HJ. Hematology: Basic Principles and Practice. New York: Churchill Livingstone; 1991. 82–86.
   Google Scholar
• Jandl JH. Blood: Textbook of Hematology, 2nd. Boston: Little, Brown; 1996.
   Google Scholar
• Hevehan DL, Papoutsakis ET, Miller WM. Physiologically significant effects of pH and oxygen tension on granulopoiesis. Exp Hematol. 2000;28:267–75.
   PubMed Web of Science ®Google Scholar
• Cipolleschi MG, D'Ippolito G, Bernabei PA, Caporale R, Nannini R, Mariani M, . Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro. Exp Hematol. 1997;25:1187–94.
   PubMed Web of Science ®Google Scholar
• LaIuppa JA, Papoutsakis ET, Miller WM. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages. Exp Hematol. 1998;26:835–43.
   PubMed Web of Science ®Google Scholar
• McAdams TA, Miller WM, Papoutsakis ET. pH is a potent modulator of erythroid differentiation. Br J Haematol. 1998;103:317–25.
   PubMed Web of Science ®Google Scholar
• Yang H, Miller WM, Papoutsakis ET. Higher pH promotes megakaryocytic maturation and apoptosis. Stem Cells. 2002;20:320–8.
   PubMed Web of Science ®Google Scholar
• Debili N, Coulombel L, Croisille L, Katz A, Guichard J, Breton-Gorius J, . Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood. 1996;88:1284–96.
   PubMed Web of Science ®Google Scholar
• Majka M, Baj-Krzyworzeka M, Kijowski J, Reca R, Ratajczak J, Ratajczak MZ. In vitro expansion of human megakaryocytes as a tool for studying megakaryocytic development and function. Platelets. 2001;12:325–32.
   PubMed Web of Science ®Google Scholar
• Birkmann J, Oez S, Smetak M, Kaiser G, Kappauf H, Gallmeier WM. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium. Stem Cells. 1997;15:18–32.
   PubMed Web of Science ®Google Scholar
• Williams JL, Pipia GG, Datta NS, Long MW. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood. 1998;91:4118–26.
   PubMed Web of Science ®Google Scholar
• LaIuppa JA, Papoutsakis ET, Miller WM. Evaluation of cytokines for expansion of the megakaryocyte and granulocyte lineages. Stem Cells. 1997;15:198–206.
   PubMed Web of Science ®Google Scholar
• Feng Y, Zhang L, Xiao ZJ, Li B, Liu B, Fan CG, . An effective and simple expansion system for megakaryocyte progenitor cells using a combination of heparin with thrombopoietin and interleukin-11. Exp Hematol. 2005; 33:1537–43.
   PubMed Web of Science ®Google Scholar
• Giammona LM, Fuhrken PG, Papoutsakis ET, Miller WM. Nicotinamide (vitamin B3) increases the polyploidisation and proplatelet formation of cultured primary human megakaryocytes. Br J Haematol. 2006;135:554–66.
   PubMed Web of Science ®Google Scholar
• Giammona LM, Panuganti S, Kemper JM, Apostolidis PA, Lindsey S, Papoutsakis ET, . Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition. Exp Hematol. 2009;37:1340–52. e3.
   PubMed Web of Science ®Google Scholar
• Takayama N, Nishikii H, Usui J, Tsukui H, Sawaguchi A, Hiroyama T, . Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood. 2008;111:5298–306.
   PubMed Web of Science ®Google Scholar
• Ciurea SO, Hoffman R. Cytokines for the treatment of thrombocytopenia. Semin Hematol. 2007;44:166–82.
   PubMed Web of Science ®Google Scholar
• Fukushima-Shintani M, Suzuki K, Iwatsuki Y, Abe M, Sugasawa K, Hirayama F, . AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis. Exp Hematol. 2008;36:1337–42.
   PubMed Web of Science ®Google Scholar
• Tijssen MR, van Hennik PB, di Summa F, Zwaginga JJ, van der Schoot CE, Voermans C. Transplantation of human peripheral blood CD34-positive cells in combination with ex vivo generated megakaryocytes results in fast platelet formation in NOD/SCID mice. Leukemia. 2008;22:203–8.
   PubMed Web of Science ®Google Scholar
• van den Oudenrijn S, von dem Borne AE, de Haas M. Influence of medium components on ex vivo megakaryocyte expansion. J Hematother Stem Cell Res. 2001;10:193–200.
   PubMedGoogle Scholar
• Rossi B, Zanolin E, Vincenzi C, Diani F, Pizzolo G, de Wynter E, . Effect of addition of FLT-3 ligand and megakaryocyte growth and development factor on hemopoietic cells in serum-free conditions. Stem Cells Dev. 2004;13:362–71.
   PubMed Web of Science ®Google Scholar
• Bertolini F, Battaglia M, Pedrazzoli P, Da Prada GA, Lanza A, Soligo D, . Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood. 1997;89: 2679–88.
   PubMed Web of Science ®Google Scholar
• Perez LE, Rinder HM, Wang C, Tracey JB, Maun N, Krause DS. Xenotransplantation of immunodeficient mice with mobilized human blood CD34+ cells provides an in vivo model for human megakaryocytopoiesis and platelet production. Blood. 2001;97:1635–43.
   PubMed Web of Science ®Google Scholar
• Decaudin D, Vantelon JM, Bourhis JH, Farace F, Bonnet ML, Guillier M, . Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma. Bone Marrow Transplant. 2004;34:1089–93.
   PubMed Web of Science ®Google Scholar
• Scheding S, Bergmannn M, Rathke G, Vogel W, Brugger W, Kanz L. Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapy. Haematologica. 2004;89:630–1.
   PubMed Web of Science ®Google Scholar
• Prince HM, Simmons PJ, Whitty G, Wall DP, Barber L, Toner GC, . Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells. Br J Haematol. 2004;126:536–45.
   PubMed Web of Science ®Google Scholar
• Kratz-Albers K, Scheding S, Mohle R, Buhring HJ, Baum CM, Mc Kearn JP, . Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin. Exp Hematol. 2000;28:335–46.
   PubMed Web of Science ®Google Scholar
• Proulx C, Boyer L, Hurnanen DR, Lemieux R. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand. J Hematother Stem Cell Res. 2003;12:179–88.
   PubMedGoogle Scholar
• Boyer L, Robert A, Proulx C, Pineault N. Increased production of megakaryocytes near purity from cord blood CD34+ cells using a short two-phase culture system. J Immunol Meth. 2008;332:82–91.
   PubMed Web of Science ®Google Scholar
• Kogler G, Callejas J, Sorg RV, Wernet P. An eight-fold ex vivo expansion of long-term culture-initiating cells from umbilical cord blood in stirred suspension cultures. Bone Marrow Transplant. 1998;21(Suppl 3):S48–53.
   Google Scholar
• Collins PC, Miller WM, Papoutsakis ET. Stirred culture of peripheral and cord blood hematopoietic cells offers advantages over traditional static systems for clinically relevant applications. Biotechnol Bioeng. 1998;59:534–43.
   PubMed Web of Science ®Google Scholar
• Zandstra PW, Eaves CJ, Piret JM. Expansion of hematopoietic progenitor cell populations in stirred suspension bioreactors of normal human bone marrow cells. Bio/technology (Nature Publishing Company). 1994;12:909–14.
   PubMedGoogle Scholar
• de Leon A, Mayani H, Ramirez OT. Design, characterization and application of a minibioreactor for the culture of human hematopoietic cells under controlled conditions. Cytotechnology. 1998;28:127–38.
   PubMed Web of Science ®Google Scholar
• Collins PC, Nielsen LK, Patel SD, Papoutsakis ET, Miller WM. Characterization of hematopoietic cell expansion, oxygen uptake, and glycolysis in a controlled, stirred-tank bioreactor system. Biotechnol Prog. 1998;14:466–72.
   PubMed Web of Science ®Google Scholar
• Balduini A, Pallotta I, Malara A, Lova P, Pecci A, Viarengo G, . Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. J Thromb Haemost. 2008;6:1900–7.
   PubMed Web of Science ®Google Scholar